Palonosetron 0.5mg
| Product Overview |
| Generic Name | Palonosetron 0.5mg |
| Brand Name(s) | Aloxi |
| Form | Oral Capsule |
| Strength | 0.5 mg |
| Therapeutic Class | 5-HT3 receptor antagonist, antiemetic |
| ATC Code | A04AA05 |
| Manufacturing & Regulatory |
| Manufacturer | Pfizer |
| Country | Mexico, India |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | Batch-specific |
| Free Sale Certificate | Yes |
| Logistics & Export |
| MOQ | 10 units |
| Shelf Life | 36 months |
| Storage | 15–30 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
| Documentation |
| Certificate of Analysis (COA) | Yes |
| SDS | Yes—for API and finished product |
| CTD Summary | CTD from originator; generic use abbreviated formats |
Description
Indications & Usage: Prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) and Prevention of postoperative nausea and vomiting (PONV)
Request for Quote
